
Joseph R. Bertino Memorial Lecture Series
Wednesday, November 18th, 2026
Rutgers Cancer Institute, 195 Little Albany St., New Brunswick, NJ
Auditorium A, 12 – 1 PM
This event will celebrate the life of Dr. Joseph R. Bertino, former Interim Director and Chief Scientific Officer of Rutgers Cancer Institute, and examine clinical, laboratory and translational research in the areas of cancer and hematologic disorders. Details and a formal agenda to follow. We hope you will join us.
To support the Joseph R. Bertino Memorial Lecture Series, please visit raise.rutgersfoundation.org/event/bertino.

Guest Speaker: Carlos Cordon-Cardo, MD, PhD, Icahn School of Medicine at Mount Sinai
Dr. Carlos Cordon-Cardo earned his medical degree from the Autonomous University of Barcelona and his PhD in Cell Biology and Genetics from Cornell University. He is Professor and Chair of the Department of Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai in New York. He previously held senior academic positions at Columbia University and Memorial Sloan Kettering Cancer Center, where he founded and served as the first Director of the Division of Molecular Pathology. A pioneer in molecular oncologic pathology and systems pathology, Dr. Cordon-Cardo has made major contributions to understanding the molecular mechanisms of cancer, identifying therapeutic targets, and advancing precision medicine. His work has also helped establish integrated approaches combining molecular pathology, digital pathology, computational modeling, and artificial intelligence to improve cancer diagnosis, prognostication, and therapeutic decision-making. During the COVID-19 pandemic, he led the development of comprehensive molecular and serologic diagnostic platforms for SARS-CoV-2.
He has maintained continuous NIH funding for approximately three decades and has served as principal investigator on numerous NCI-supported research programs. His scientific work has received more than 137,000 citations, with an h-index of 181 according to Google Scholar. ScholarGPS Highly Ranked Scholars™ recently placed him among the top 0.05% of researchers worldwide by scientific impact. Throughout his career, he has trained and mentored more than 100 biomedical investigators, many of whom now hold leadership positions in academic medicine and research. Among his major honors are election to the National Academy of Inventors, membership in Academia Europaea, Fellowship of the Royal Society of Medicine, the Gold Medal of the Swedish Society of Medicine, the Distinguished Alumnus Award of Weill Cornell Graduate School of Medical Sciences, the Jacobi Medallion of the Icahn School of Medicine at Mount Sinai, and an Honorary Doctorate from the University of Barcelona.
Previous Years
2025 Program
The 2025 program featured Jonathan Chernoff, MD, PhD, Cancer Center Director, Senior Vice President, and Staney P. Reimann Chair in Oncology Research at Fox Chase Cancer Center. His talk was titled, "Drugging Ras: Up, Down, and Sideways."
2024 Program
View the 2024 program with Yang-Yu Liu, PhD, Associate Professor, Harvard Medical School and Associate Scientist, Brigham and Women’s Hospital.
2023 Program
View the 2023 program with Arnold J. Levine, PhD, Professor Emeritus of Systems Biology, Institute for Advanced Study, who discussed the 'Exploration of the Genetic and Genomic Causes of Cancers of African or European Ancestry.'
2022 Program
View the inaugural 2022 program with speakers:
Frederick W. Alt, PhD ~ 'Anti-Cancer Drug Resistance, Gene Amplification & Beyond'
Charles A. Janeway Professor of Pediatrics Professor of Genetics, Harvard Medical School Investigator, Howard Hughes Medical Institute Director, Program in Cellular & Molecular Medicine, Boston Children’s Hospital
Bruce A. Chabner, MD ~ 'Travels with Joe Along the Folate Highway'
Allen Distinguished Investigator Clinical Director Emeritus, Massachusetts General Hospital
Carl H. June, MD ~ 'Engineered T-Cells as Cancer Therapy'
Director, Center for Cellular Immunotherapies Director, Parker Institute for Cancer Immunotherapy Richard W. Vague Professor in Immunotherapy Professor of Medicine, University of Pennsylvania